A second incriminated mechanism is represented by the COVID-19-induced coagulopathy, which, unlike other coagulopathies, is characterized by elevated fibrinogen levels and extensive fibrinolysis (elevated D-dimers), but with negligible alterations in platelet count, prothrombin time, and antithrombin levels. This evidence concerns the gene F2 and COVID-19.